THRD Operating Cash Flow
-$41.69MTTM · USD
Period ending:
THRD FY Operating Cash FlowUSD
$0.00-$34.92M
2020-12-312024-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
THRD operating cash flow history
Cash generated from core business operations. The available annual fiscal periods series contains 5 observations from Dec 31, 2020 to Dec 31, 2024.
| Period ending | Operating Cash Flow (USD) |
|---|---|
| -34,503,000 | |
| -20,425,000 | |
| -34,917,000 | |
| -15,746,000 | |
| -9,187,000 |
Compare operating cash flow
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) operating cash flow
- Bridgebio Pharma Inc (BBIO) operating cash flow
- Brightspring Health Services Inc (BTSG) operating cash flow
- Madrigal Pharmaceuticals Inc (MDGL) operating cash flow
- Ensign Group Inc (ENSG) operating cash flow
- Glaukos Corp (GKOS) operating cash flow
- Vaxcyte Inc (PCVX) operating cash flow
- Krystal Biotech Inc (KRYS) operating cash flow
All THRD financial metrics · THRD stock overview · How to interpret financial metrics
